• Education, realistic expectations needed for presbyopia-correcting drops

    1 month ago - By Healio

    Vuity is our first FDA-approved pharmaceutical agent labeled for the treatment of a refractive error, presbyopia.
    Vuity (pilocarpine hydrochloride ophthalmic solution 1.25%, Allergan) has now been on the market for 6 months. I would like to share a few personal learnings. I want to disclose that I consult widely in the field of refractive error correction including contact lenses, corneal and lens-based refractive surgery, and pharmaceuticals, including miotic drops and other topical agents for presbyopia and myopia.
    First, presbyopia is another refractive error like myopia, hyperopia and
    Read more ...

     

  • Presbyopia-correcting drops broaden options for younger patients

    Presbyopia-correcting drops broaden options for younger patients

    1 month ago - By Healio

    Presbyopia is a ubiquitous and progressive symptom of aging that was previously only treatable with reading glasses, contacts or surgery, but patients now have a new option to help their aging eyes: eye drops.
    The FDA approval of Vuity (pilocarpine hydrochloride ophthalmic solution 1.25%, Allergan) in 2021 marked a paradigm shift in presbyopia treatment with a new noninvasive approach.
    “There is a large number of presbyopes in the U.S., maybe close to 120 million,” Jay S. Pepose, MD, PhD, founder and medical director of Pepose Vision Institute in St. Louis, said. “To have a
    Read more ...